New Delhi, April 8 Biocon Ltd announced on Wednesday that its subsidiary, Biocon Pharma Ltd, has received approval from the US health regulator for its genetically engineered version of dapagliflozin tablets, indicated for reducing blood sugar levels in adults with type 2 diabetes mellitus.The...
New Delhi, April 7 Alembic Pharmaceuticals Ltd announced on Tuesday that it has received final approval from the US health regulator for its generic version of dapagliflozin tablets, used to control blood sugar levels in people with type-2 diabetes.The approval from the US Food & Drug...
New Delhi, March 25 Pharma major Lupin Ltd announced on Wednesday that it has received tentative approval from the US health regulator for its generic version of Pitolisant tablets, indicated for the treatment of excessive daytime sleepiness.The tentative approval from the US Food and Drug...
abbreviated new drug application
drug development
drug manufacturing
excessive daytime sleepiness
generic pharmaceuticals
healthcare
india
lupin ltd
nagpur
pharmaceutical approval
pharmaceutical industry
pitolisant
regulatory filings
tablet
us food and drug administration (usfda)